Pharmaceutical Research Insight

Conventional wisdom says that big ideas usually come from brilliant minds working alone. That never made a lot of sense to Don deBethizy.

Affymetrix, Inc. (NASDAQ:AFFX) today announced that based on preliminary financial data, the Company expects to generate positive operating income and net income on a GAAP basis for the fourth-quarter of 2010.

Insight Genetics today announced that it has been awarded a $200,000 Phase I Small Business Innovation Research (SBIR) contract from the National Cancer Institute (NCI) to develop a new test for lung cancer patients.